Censo Biotechnologies (Axol Bioscience Ltd.) Revenue

Biotechnology Research • Roslin, Scotland, United Kingdom • 1-10 Employees

Censo Biotechnologies (Axol Bioscience Ltd.) revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	$180,700

Key Contact at Censo Biotechnologies (Axol Bioscience Ltd.)

Tara Hayden

Executive Assistant to Chief Executive Officer

Company overview

Headquarters	Roslin Innovation Centre, Charnock Bradley Building, Easter Bush, Midlothian EH25 9RG, GB
Phone number	+441315140880
Websites	axolbio.com censobio.com
NAICS	541714
Keywords	Alzheimer'S, Assay Development, Drug Discovery, Inflammation, Neurons, Stem Cell, Neurodegeneration, Parkinson'S, Phenotypic Screening, Target Validation, Dendritic Cells, Neurological Disease, Gene Editing, Contract Research Services, Ipsc, Ipsc-Based Disease Modelling, Macrophages, Compound Testing, Microglia, Ipsc Reprogramming
Founded	2016
Employees	1-10
Socials

Censo Biotechnologies (Axol Bioscience Ltd.) Email Formats

Censo Biotechnologies (Axol Bioscience Ltd.) uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@axolbio.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@axolbio.com	100%

About Censo Biotechnologies (Axol Bioscience Ltd.)

Axol Bioscience is a leading provider of human induced pluripotent stem cell (iPSC) technologies, specializing in the manufacture of high-performance iPSC-derived cells and the delivery of industry-leading laboratory services. With over a decade of expertise, Axol partners with global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions to advance the use of iPSC-based models in drug discovery and disease research. We operate across five key areas, neuroscience (including ALS, Alzheimer’s, Huntington’s, Parkinson’s, neuroinflammation), pain & sensation, ophthalmology (Dry-AMD, ophthal-inflammation), dermatology, and cardiovascular. Axol offers scalable solutions including iPSC banking, reprogramming, gene editing, cell manufacturing, and quality control. The company is committed to closing the translational gap, developing physiologically relevant in vitro systems that improve consistency and relevance in human disease modeling and compound testing. Axol is recognized for its scientific excellence, transparent collaboration, and rigorous quality standards, with manufacturing operations certified to ISO 9001:2015.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Censo Biotechnologies (Axol Bioscience Ltd.) has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Censo Biotechnologies (Axol Bioscience Ltd.)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-05-17	1	$180,700

Funding Insights

$180,700

Total funding amount

$180,700

Most recent funding amount

Number of funding rounds

Frequently asked questions

Censo Biotechnologies (Axol Bioscience Ltd.) is located in Roslin, Scotland, GB.

You can reach Censo Biotechnologies (Axol Bioscience Ltd.) at +441315140880.

Censo Biotechnologies (Axol Bioscience Ltd.) generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Censo Biotechnologies (Axol Bioscience Ltd.) has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Censo Biotechnologies (Axol Bioscience Ltd.) was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Censo Biotechnologies (Axol Bioscience Ltd.) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Censo Biotechnologies (Axol Bioscience Ltd.) has raised a total of $180,700 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Censo Biotechnologies (Axol Bioscience Ltd.)

Tara Hayden

Executive Assistant to Chief Executive Officer

4.8

40,000 users